Japan· JP-6135400F1124
ホスホマイシンナトリウム
A fosfomycin product containing ホスホマイシンナトリウム, registered in Japan by 高田製薬, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Fosfomycin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01XX01 (fosfomycin), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 10 of them publish a price we can compare per daily dose
Fosfomycin · ATC J01XX01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fosfomycin costs, country by country.
Normalised to the WHO defined daily dose (3 g), the median price runs from $3.86 in Spain to $16.40 in Switzerland — a ×4.2 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fosfomycin · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$16.40
- ES Spain$3.86
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ホスホマイシンナトリウム
- Manufacturer
- 高田製薬
- Country
- Japan (JP)
- ATC code
- J01XX01
- ATC class
- Fosfomycin
- Defined daily dose
- 3 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for fosfomycin.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fosfomycin · interactions on record
3 records
- 2 moderate
- 1 minor
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- BalsalazideA07EC04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01XX01
Fosfomycin, as other registers publish it.
- PolandAfasturalExeltis Poland Sp. z o.o.
- GermanyAfosfolAxunio Pharma Gmbh
- United KingdomAlexi 3g granules for oral solution sachetsNordic Pharma Ltd
- ItalyBERNYFIDIA SPECIALTY S.R.L.
- United StatesContepoMeitheal Pharmaceuticals Inc.
- ItalyDAFOCISTARISTO PHARMA GMBH
- ItalyDANIFOSPHARMACARE S.R.L.
- PolandFasflowAurovitas Pharma Polska Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e14629ec-776c-4ff0-98d5-ac5544795244 GET /v1/drugs/e14629ec-776c-4ff0-98d5-ac5544795244?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "500mg1瓶",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6135400F1124",
"category": "注射薬",
"price_yen": 543,
"generic_name": "ホスホマイシンナトリウム",
"product_name_jp": null,
"therapeutic_class": "6135",
"transitional_expiry": null
}See everything about fosfomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.